CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project

Internal and Emergency Medicine

Volumn 10, Issue 7, 2015, Pages 815-821

  Sciacqua, Angela ^a   Perticone, Maria ^a   Tripepi, Giovanni ^b   Tassone, Eliezer J ^a   Cimellaro, Antonio ^a   Mazzaferro, Deborah ^a   Sesti, Giorgio ^a   Perticone, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

Author keywords

Atrial fibrillation; Cardiovascular risk factors; CHA2DS2 VASc score; CHADS2 score

Indexed keywords

AGED; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COMPLICATION; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

AGED; ATRIAL FIBRILLATION; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; VASCULAR DISEASES;

EID: 84942987807     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-015-1243-3     Document Type: Article

References (25)

1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870
2. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 57:e101–e198
3. Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG et al (2009) Atrial fibrillation significantly increases total mortality and stroke risk be-yond that conveyed by the CHADS2 risk factors. Pacing Clin Electrophysiol 32:981–986
4. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272
5. Naccarelli GV, Johnston SS, Lin J, Patel PP, Schulman KL (2010) Cost burden of cardiovascular hospitalization and mortality in ATHENA- like patients with atrial fibrillation/atrial flutter in the United States. Clin Cardiol 33:270–279
6. Lee WC, Lamas GA, Balu S, Spalding J, Wang Q, Pashos CL (2008) Direct treatment cost of atrial fibrillation in the elderly american population: a Medicare perspective. J Med Econ 11:281–298
7. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A et al (2009) Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation 119:606–618
8. Lip GY, Halperin JL (2010) Improving stroke risk stratification in atrial fibrillation. Am J Med 123:484–488
9. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844
10. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP et al (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461
11. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS et al (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477
12. Olesen JB, Gislason GH, Torp-Pedersen C, Lip GY (2012) Atrial fibrillation and vascular disease. A bad combination. Clin Cardiol 35:15–20
13. Violi F, Lip GY, Basili S (2012) Peripheral artery disease and atrial fibrillation: a potentially dangerous combination. Intern Emerg Med 7:213–218
14. Expert Panel on Detection (2001) Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
16. Salonen R, Haapanen A, Salonen JT (1991) Measurements of intima–media thickness of common carotid arteries with high resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol 17:225–230
17. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F et al (2001) Obesity and body fat distribution induce endothelial dysfunction by oxidative stress. Protective effect of vitamin C. Diabetes. 50:159–165
18. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Rooij FJ, Lip GY, Witteman JC (2007) Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 167:382–387
19. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima–media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96:1432–1437
20. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D’Agostino RB et al (2009) Development of a risk score for atrial fibrillation in the community; the Framingham Heart Study. Lancet 373:739–745
21. Zoccali C, Maio R, Tripepi G, Mallamaci F, Perticone F (2006) Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 17:S64–S68
22. Nelson SE, Shroff GR, Li S, Herzog CA (2012) Impact of chronic kidney disease on risk of incident atrial fibrillation on risk of incident atrial fibrillation and subsequent survival in Medicare. J Am Heart Assoc. doi:10.1161/JAHA
23. Ehrlich JR, Hohnloser SH, Nattel S (2006) Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and exeperimental evidence. Eur Heart J 27:512–518
24. Fukunaga N, Takahashi N, Hagivara S, Kume O, Fukui A, Teshima Y et al (2012) Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm. 9:2023–2031
25. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N et al (2009) Sympathetic activation in chronic renal failure. J Am Soc Nephrol 20:933–939